» Articles » PMID: 32275481

Reduced 25(OH) Vitamin D Association with Lower Alpha-1-Antitrypsin Blood Levels in Type 2 Diabetic Patients

Overview
Journal J Am Coll Nutr
Date 2020 Apr 11
PMID 32275481
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Reduced circulating levels of 25(OH)VD are associated with an increased incidence of chronic lung diseases. Alpha-1-antitrypsin (AAT) is needed to maintain healthy lung function. This study examined the hypothesis that circulating levels of AAT are lower in adult type 2 diabetic patients and that a positive association exists between circulating AAT levels and 25(OH)VD levels in these patients. Fasting blood was obtained after written informed consent from type 2 diabetic patients (n = 80) and normal siblings or volunteers (n = 22) attending clinics at LSUHSC according to the protocol approved by the Institutional Review Board for Human studies. Plasma AAT and 25(OH)VD levels were determined using ELISA kits. HbA levels and chemistry profiles were analyzed at the clinical laboratory of LSUHSC hospital. ATT and 25(OH)VD levels were significantly lower in type 2 diabetic patients compared with those of age-matched healthy controls. There was a significant positive correlation between 25(OH)VD and ATT deficiency. AAT levels showed significant positive correlation with HDL cholesterol levels in type 2 diabetic patients. There was no correlation between AAT levels and those of HbA or with the duration of diabetes of T2D patients. These results suggest that 25(OH)VD deficiency may predispose type 2 diabetic patients to AAT deficiency. Whether reduced levels of circulating AAT indeed contribute to the increased risk for lung dysfunction in subjects with type 2 diabetes needs further investigation.

Citing Articles

SERS profiling of blood serum filtrate components from patients with type II diabetes using 100 kDa filtration devices.

Shoukat Z, Atta R, Majeed M, Nawaz H, Rashid N, Alshammari A RSC Adv. 2025; 15(4):2287-2297.

PMID: 39867317 PMC: 11755331. DOI: 10.1039/d4ra06335j.


Efficacy of Vitamin-D supplementation in improving the prognosis of H-type hypertension in elderly patients.

Zang S, Zhao Q, Xiao N, Liu S Pak J Med Sci. 2024; 40(10):2379-2383.

PMID: 39554649 PMC: 11568701. DOI: 10.12669/pjms.40.10.8464.


Dietary patterns and micronutrients in respiratory infections including COVID-19: a narrative review.

Salehi Z, Askari M, Jafari A, Ghosn B, Surkan P, Hosseinzadeh-Attar M BMC Public Health. 2024; 24(1):1661.

PMID: 38907196 PMC: 11193220. DOI: 10.1186/s12889-024-18760-y.


Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection.

Akbasheva O, Spirina L, Dyakov D, Masunova N Biochem Mosc Suppl B Biomed Chem. 2022; 16(4):271-291.

PMID: 36407837 PMC: 9668222. DOI: 10.1134/S1990750822040035.


The Induction of Alpha-1 Antitrypsin by Vitamin D in Human T Cells Is TGF-β Dependent: A Proposed Anti-inflammatory Role in Airway Disease.

Chen Y, Cheadle C, Rice L, Pfeffer P, Dimeloe S, Gupta A Front Nutr. 2021; 8:667203.

PMID: 34458299 PMC: 8397538. DOI: 10.3389/fnut.2021.667203.


References
1.
Lisowska-Myjak B, Pachecka J, Kaczynska B, Miszkurka G, Kadziela K . Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol. 2007; 43(4):88-92. DOI: 10.1007/s00592-006-0220-8. View

2.
Brode S, Ling S, Chapman K . Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ. 2012; 184(12):1365-71. PMC: 3447047. DOI: 10.1503/cmaj.111749. View

3.
Pian M, Dobbs L . Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins. Am J Physiol. 1997; 273(3 Pt 1):L634-9. DOI: 10.1152/ajplung.1997.273.3.L634. View

4.
Greulich T, Nell C, Hohmann D, Grebe M, Janciauskiene S, Koczulla A . The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database. Eur Respir J. 2016; 49(1). DOI: 10.1183/13993003.00154-2016. View

5.
Putcha N, Drummond M, Wise R, Hansel N . Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management. Semin Respir Crit Care Med. 2015; 36(4):575-91. PMC: 5004772. DOI: 10.1055/s-0035-1556063. View